The first Asian market that works changes how a leadership team thinks. The brand has proof: a channel that converts, a price that holds, a product line customers reorder. The natural next step is to take what worked and run it again in Japan, South Korea and India.
The question is not simply whether the first market's playbook was good. It is whether it was good because of that market. A playbook built in Singapore is built on Singapore's channels, regulation, prices and competitors. Those are the parts least likely to travel.
The misleading assumption is that Asia is one market with local variations. It is closer to a set of separate markets that happen to share a time zone. The risk emerges at a specific moment: when confidence is highest and the brand is about to enter markets it understands least.
Take a US skincare brand that has succeeded in Singapore through the two leading marketplaces, using a whitening serum and an anti-wrinkle cream as its hero products. Here is what changes when it tries to copy that model:
*Note: the Singapore marketplace shares are 2022 data, the most recent verified figures available. Sources: Cube Asia, Mondaq, ChemLinked Japan, Herald Business, ChemLinked Korea, Korea JoongAng Daily, Social Samosa / ClickPost, India import guide.
This matters because the same two products face four different regulatory paths. In Japan, a whitening claim makes a product a quasi-drug, which needs MHLW approval with an approved active ingredient. ChemLinked puts that at a minimum of six to eight months. In Korea, whitening and anti-wrinkle products are functional cosmetics and need MFDS review before sale. A hero product that launched quickly in Singapore can arrive late, reformulated or with weaker claims elsewhere.
The channel picture changes too. In Korea, Olive Young dominates health-and-beauty retail since rivals Lalavla and Lohbs closed. It also takes 66% of beauty-commerce app downloads, according to Sensor Tower data cited by Herald Business. A brand that won on Shopee has not yet won a buyer at Olive Young. In India, prepaid orders were only 41% of e-commerce in 2025, according to ClickPost. That changes return rates, cash cycles and the economics of a premium price point.
The obvious costs of copying the playbook are slower sell-through, higher acquisition costs and products that don't land. Executives expect those. The less obvious costs are the ones that change the economics of expansion.
1. Misread signals. When the copied model underperforms, the market gets the blame ("Japan is too hard") rather than the playbook. A company may therefore retreat from a viable market it simply entered the wrong way.
2. Capital and attention drain. Struggling markets absorb management time and budget that should be defending the proven one.
3. Regulatory rework. Products that must be reformulated or re-registered reset the launch clock, often after inventory and marketing have been committed.
4. A weaker case for expansion itself. A failed second market can lead a board to question international growth altogether, even though the first market proved it works.
The research on pace is sobering. A study of 224 multinational retailer market entries found that 48 had ended in exit. Each additional country a retailer had entered in the previous 15 years was associated with 9.5% shorter longevity in a new market (Koc, INFORMS, 2020, global retail data). Breadth of footprint was associated with longer survival. The difference is between expanding with built capability and expanding at speed.
The implication for expansion is that the first market's success is evidence of execution capability, not of a transferable formula. What transfers is the discipline used to find the formula.
What executives should consider is which parts of the playbook are genuinely portable. Brand positioning, product quality, operating discipline and the capability to learn a market usually travel. Channel mix, hero-product claims, pricing and the partner model usually do not. The decision is not "standardise or localise", but deciding in advance which layer is which.
That changes three decisions. Sequencing: a market whose claims, channels and payment norms resemble the proven market can follow quickly; one that differs on all three needs its own entry case. Product line-up: the launch range for each market should be chosen by regulatory route as well as demand, so a hero product facing a six-month approval does not hold up the whole launch. Capital allocation: each new market should be funded as a new entry with its own milestones, not as an extension of the first market's budget.
Before committing to the next market, executives should be able to answer:
☐ Which elements of our first-market success depended on that market's channels, rules or prices?
☐ Does our hero product's claim change regulatory category in the new market?
☐ Which retailer or platform controls access to our customer there?
☐ How do payment, delivery and price expectations change our unit economics?
☐ What would tell us the playbook, not the market, is the problem?
The key principle to success in Asia is tailored repeatable expansion: building a structured way to enter each market, rather than repeating the last market's answers. The capability that won the first market is the asset. The playbook it produced is only one market's answer.
If your first Asian market is working and you are planning the next, Samana works with Expansion Brands to separate what travels from what doesn't, before the capital is committed.
Sources, all accessed 20 October 2026.
• Cube Asia – Singapore e-commerce market 2025 (Shopee/Lazada GMV share, 2022 data)
• Mondaq – Selling cosmetic products in Singapore (HSA notification)
• ChemLinked – Japan quasi-drug regulation (updated 28 Aug 2026)
• ChemLinked – South Korea cosmetic regulation (updated 17 Aug 2026)
• Herald Business – Korean beauty platform market (1 Jul 2026)
• Korea JoongAng Daily – Korea cosmetics exports record (6 Jan 2025, MFDS data)
• Social Samosa – Prepaid e-commerce orders rise to 41% (ClickPost, 30 Dec 2025)
• Importing cosmetics into India – compliance guide (CDSCO timelines)
• Koc, "International Seller Beware: The Perils of Global Retailing", INFORMS (3 Apr 2020)
